{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:54:33Z","timestamp":1785430473846,"version":"3.56.0"},"reference-count":33,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Background:\u00a0Renal hyperparathyroidism is a frequent complication among patients with kidney failure. Data on outcomes following parathyroidectomy in patients undergoing kidney replacement therapy (KRT) remain limited in South Africa (SA). This study aimed to assess postoperative surgical and biochemical complication rates and disease recurrence.\nMethods:\u00a0We conducted a retrospective cohort study of adult KRT patients who underwent parathyroidectomy for renal hyperparathyroidism at Tygerberg Hospital over 7 years. Kaplan-Meier and univariate logistic regression analyses were used to determine predictors of recurrence.\nResults:\u00a0Forty-six patients underwent parathyroidectomy. Two-thirds were female with a mean age of 40.7 \u00b1 8.50 years. Preoperative serum calcium and parathyroid hormone (PTH) concentrations were 2.41 \u00b1 0.27 mmol\/L and 176.7 (interquartile range [IQR] 124.4\u2013245.1) pmol\/L, respectively. Most patients (80%) underwent subtotal parathyroidectomy. The most common postoperative complication was hungry bone syndrome (HBS), which occurred in 98% of patients, and the postoperative total calcium concentration was 1.63 \u00b1 0.28 mmol\/L, observed on day 4 or later. Overall, recurrence of renal hyperparathyroidism occurred in 15% of patients. There were no predictors of recurrence on univariate logistic regression.\nConclusion:\u00a0A lower recurrence rate was observed in total parathyroidectomy and a lower hypoparathyroidism rate in subtotal parathyroidectomy (SPTX). Hungry bone syndrome was found to be the most frequent postoperative complication, reflecting more advanced disease at the time of surgery.\nContribution:\u00a0In the future, the focus at Tygerberg Hospital should be on earlier surgical referral considering our limited medical options, and the decision-making regarding the surgical procedure should be discussed in a multidisciplinary team, with a focus on individualised priorities.<\/jats:p>","DOI":"10.4102\/jcmsa.v4i1.316","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:02:55Z","timestamp":1770364975000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Tholakele Sabela, Nontembiso Mhlana, Wilhelmina Conradie, Mogamat-Yazied Chothia"],"prefix":"10.4102","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6389-2660","authenticated-orcid":false,"given":"Tholakele","family":"Sabela","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05bk57929","id-type":"ROR","asserted-by":"publisher"}],"name":"Stellenbosch University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5023-6797","authenticated-orcid":false,"given":"Nontembiso","family":"Mhlana","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05bk57929","id-type":"ROR","asserted-by":"publisher"}],"name":"Stellenbosch University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9220-331X","authenticated-orcid":false,"given":"Wilhelmina","family":"Conradie","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05bk57929","id-type":"ROR","asserted-by":"publisher"}],"name":"Stellenbosch University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9801-1300","authenticated-orcid":false,"given":"Mogamat-Yazied","family":"Chothia","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05bk57929","id-type":"ROR","asserted-by":"publisher"}],"name":"Stellenbosch University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Steinl GK, Kuo JH. Surgical management of secondary hyperparathyroidism. Kidney Int Rep. 2021;6:254\u2013264. https:\/\/doi.org\/10.1016\/j.ekir.2020.11.023","DOI":"10.1016\/j.ekir.2020.11.023"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Zhang Y, Lu Y, Feng S, Zhan Z, Shen H. Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Ren Fail. 2019;41(1):921\u2013929. https:\/\/doi.org\/10.1080\/0886022X.2019.1666724","DOI":"10.1080\/0886022X.2019.1666724"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Costa-Hong V, Jorgetti V, Gowdak LHW, Moyses RMA, Krieger EM, De Lima JJG. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery. 2007;142:699\u2013703. https:\/\/doi.org\/10.1016\/j.surg.2007.06.015","DOI":"10.1016\/j.surg.2007.06.015"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Martin K, Gonz\u00e1lez E. Metabolic bone disease in chronic kidney disease. J Am Soc Nephrol. 2007;18(3):875\u2013885. https:\/\/doi.org\/10.1681\/ASN.2006070771","DOI":"10.1681\/ASN.2006070771"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Pitt SC, Sippel RS, Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am. 2009;89:1227\u20131239. https:\/\/doi.org\/10.1016\/j.suc.2009.06.011","DOI":"10.1016\/j.suc.2009.06.011"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Van der Plas WY, Noltes ME, Van Ginhoven TM, Kruijff S. Secondary and tertiary hyperparathyroidism: A narrative review. Scand J Surg 2020;109:271\u2013278. https:\/\/doi.org\/10.1177\/1457496919866015","DOI":"10.1177\/1457496919866015"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Ketteler M, Block G, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) guideline update: What\u2019s changed and why it matters. Kidney Int. 2017;92(1):26\u201336. https:\/\/doi.org\/10.1016\/j.kint.2017.04.006","DOI":"10.1016\/j.kint.2017.04.006"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Madorin C, Owen RP, Fraser WD, et al. The surgical management of renal hyperparathyroidism. Eur Arch Otorhinolaryngol. 2012;269:1565\u20131576. https:\/\/doi.org\/10.1007\/s00405-011-1833-2","DOI":"10.1007\/s00405-011-1833-2"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Rajeev P, Lee KY, Tang XJ, Goo TT, Tan WB, Ngiam KY. Outcomes of parathyroidectomy in renal hyperparathyroidism in patients with No access to renal transplantation in Singapore. Int J Surg. 2016;25:64\u201368. https:\/\/doi.org\/10.1016\/j.ijsu.2015.11.005","DOI":"10.1016\/j.ijsu.2015.11.005"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Milas M, Weber CJ. Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism. Surgery. 2004;136:1252\u20131260. https:\/\/doi.org\/10.1016\/j.surg.2004.06.055","DOI":"10.1016\/j.surg.2004.06.055"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Apetrii M, Goldsmith D, Nistor I, et al. Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) \u2013 A systematic review and meta-analysis. PLoS One. 2017;12:e0187025. https:\/\/doi.org\/10.1371\/journal.pone.0187025","DOI":"10.1371\/journal.pone.0187025"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Wetmore JB, Liu J, Do TP,. Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy. Nephrol Dial Transplant. 2016;31:103\u2013111. https:\/\/doi.org\/10.1093\/ndt\/gfv291","DOI":"10.1093\/ndt\/gfv291"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2018;13:952\u2013961. https:\/\/doi.org\/10.2215\/CJN.10390917","DOI":"10.2215\/CJN.10390917"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Anderson K, Ruel E, Adam MA, et al. Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes. Am J Surg. 2017;214:914\u2013919. https:\/\/doi.org\/10.1016\/j.amjsurg.2017.07.018","DOI":"10.1016\/j.amjsurg.2017.07.018"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Kim MS, Kim GH, Lee CH, Park JS, Lee JY, Tae K. Surgical outcomes of subtotal parathyroidectomy for renal hyperparathyroidism. Clin Exp Otorhinolaryngol. 2020;13:173\u2013178. https:\/\/doi.org\/10.21053\/ceo.2019.01340","DOI":"10.21053\/ceo.2019.01340"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Goldfarb M, Gondek SS, Lim SM, Farra JC, Nose V, Lew JI. Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. World J Surg. 2012;36:1314\u20131319. https:\/\/doi.org\/10.1007\/s00268-012-1560-x","DOI":"10.1007\/s00268-012-1560-x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Jain N, Reilly RF. Hungry bone syndrome. Curr Opin Nephrol Hypertens. 2017;26:250\u2013255. https:\/\/doi.org\/10.1097\/MNH.0000000000000327","DOI":"10.1097\/MNH.0000000000000327"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Witteveen JE, Thiel SV, Romijn JA, Hamdy NAT. Hungry bone syndrome: Still a challenge in the post-operative management of primary hyperparathyroidism: A systematic review of the literature. Eur J Endocrinol. 2013;168:45\u201353. https:\/\/doi.org\/10.1530\/EJE-12-0528","DOI":"10.1530\/EJE-12-0528"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Tominaga Y, Kakuta T, Yasunaga C, Nakamura M, Kadokura Y, Tahara H. Evaluation of parathyroidectomy for secondary and tertiary hyperparathyroidism by the parathyroid surgeons\u2019 society of Japan. Ther Apher Dial. 2016;20:6\u201311. https:\/\/doi.org\/10.1111\/1744-9987.12352","DOI":"10.1111\/1744-9987.12352"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Chainapapong K. Outcome of parathyroidectomy for renal hyperparathyroidism: A single-center experience. Thai J Surg. 2022;43:18\u201325. https:\/\/doi.org\/10.35755\/jmedassocthai.2022.01.13231","DOI":"10.35755\/jmedassocthai.2022.01.13231"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Duggan WP, Patterson R, Smyth NM, et al. A retrospective analysis of the management of renal hyperparathyroidism; evaluating changes in practice and outcome in an era of calcimimetics. Langenbecks Arch Surg. 2025;410:172. https:\/\/doi.org\/10.1007\/s00423-025-03744-2","DOI":"10.1007\/s00423-025-03744-2"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Liu ME, Qiu NC, Zha SL, et al. To assess the effects of parathyroidectomy (TPTX versus TPTX+AT) for secondary hyperparathyroidism in chronic renal failure: A systematic review and meta-analysis. Int J Surg. 2017;44:353\u2013362. https:\/\/doi.org\/10.1016\/j.ijsu.2017.06.029","DOI":"10.1016\/j.ijsu.2017.06.029"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Zhu J, Wu Y, Huang T, Jiang G, Yang Z. Efficacy and safety of total parathyroidectomy with autotransplantation vs. subtotal parathyroidectomy for secondary hyperparathyroidism: A retrospective study. Heliyon. 2023;9:e15752. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15752","DOI":"10.1016\/j.heliyon.2023.e15752"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Isaksson E, Ivarsson K, Akaberi S, et al. Total versus subtotal parathyroidectomy for secondary hyperparathyroidism. Surgery. 2019;165:142\u2013150. https:\/\/doi.org\/10.1016\/j.surg.2018.04.076","DOI":"10.1016\/j.surg.2018.04.076"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Li C, Lv L, Wang H, et al. Total parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: Systematic review and meta-analysis. Ren Fail. 2017;39(1):678\u2013687. https:\/\/doi.org\/10.1080\/0886022X.2017.1363779","DOI":"10.1080\/0886022X.2017.1363779"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Kuo YC, Wang SY, Hung YL, et al. Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment. Front Endocrinol. 2023;14:1063837. https:\/\/doi.org\/10.3389\/fendo.2023.1063837","DOI":"10.3389\/fendo.2023.1063837"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Wu SY, Chiu YC, Hsu SN, Yu FC, Lin SH, Shih ML. The patterns of persistence and recurrence following parathyroidectomy for renal hyperparathyroidism: A 10-year review. J Med Sci. 2024;44:74\u201379. https:\/\/doi.org\/10.4103\/jmedsci.jmedsci_181_23","DOI":"10.4103\/jmedsci.jmedsci_181_23"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Black KA, Galata G, Schulte KM, Hubbard JG. Comparing subtotal parathyroidectomy and total parathyroidectomy with autotransplantation in renal transplant recipients. Gland Surg. 2023;12:1060\u20131066. https:\/\/doi.org\/10.21037\/gs-23-54","DOI":"10.21037\/gs-23-54"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Ho LY, Wong PN, Sin HK, et al. Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol. 2017;18:12. https:\/\/doi.org\/10.1186\/s12882-016-0421-5","DOI":"10.1186\/s12882-016-0421-5"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Chen J, Jia X, Kong X, Wang Z, Cui M, Xu D. Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: A systematic review and meta-analysis. Nephrology. 2017;22:388\u2013396. https:\/\/doi.org\/10.1111\/nep.12801","DOI":"10.1111\/nep.12801"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Bilezikian JP. Hypoparathyroidism. J Clin Endocrinol Metab. 2020;105:1722\u20131736. https:\/\/doi.org\/10.1210\/clinem\/dgaa113","DOI":"10.1210\/clinem\/dgaa113"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Brandi ML, Bilezikian JP, Shoback D, et al. Management of hypoparathyroidism: Summary statement and guidelines. J Clin Endocrinol Metab. 2016;101:2273\u20132283. https:\/\/doi.org\/10.1210\/jc.2015-3907","DOI":"10.1210\/jc.2015-3907"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"B\u00fcttner M, Singer S, Taylor K. Quality of life in patients with hypoparathyroidism receiving standard treatment: An updated systematic review. Endocrine. 2024;85:80\u201390. https:\/\/doi.org\/10.1007\/s12020-024-03807-2","DOI":"10.1007\/s12020-024-03807-2"}],"container-title":["Journal of the Colleges of Medicine of South Africa"],"original-title":[],"link":[{"URL":"https:\/\/jcmsa.org.za\/index.php\/jcmsa\/article\/view\/316\/898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:03:08Z","timestamp":1770364988000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcmsa.org.za\/index.php\/jcmsa\/article\/view\/316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.4102\/jcmsa.v4i1.316","relation":{},"ISSN":["3105-4331","2960-110X"],"issn-type":[{"value":"3105-4331","type":"print"},{"value":"2960-110X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"article-number":"a316"}}